Dendritic Cells Archive - Seite 21 von 106 - IOZK

Trial watch: dendritic cell vaccination for cancer immunotherapy

2019-07-18/in Dendritic Cells, International Publications /von 2019-07-18 / Oncoimmunology 2019;8(11):e1638212

Hepatocellular carcinoma: Mechanisms of progression and immunotherapy

2019-07-07/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2019-07-07 / World J. Gastroenterol. 2019 Jul;25(25):3151-3167

Immunotherapy for hepatocellular carcinoma: Current and future

2019-06-28/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2019-06-28 / World J. Gastroenterol. 2019 Jun;25(24):2977-2989

Can Dendritic Cell Vaccination Prevent Leukemia Relapse?

2019-06-22/in Acute Leukemia, Dendritic Cells, International Publications /von 2019-06-22 / Cancers (Basel) 2019 Jun;11(6)

Dendritic cell/cytokine-induced killer cell-based immunotherapy in lung cancer: What we know and future landscape

2019-06-21/in Dendritic Cells, International Publications, NSCLC /von 2019-06-21 / J. Cell. Physiol. 2020 Jan;235(1):74-86

Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1

2019-06-19/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2019-06-19 / Oncology 2019 Jun;:1-14

Safety of nivolumab in combination with dendritic cell vaccines in recurrent high-grade glioma.

2019-06-17/in Checkpoint-Inhibitors, Dendritic Cells, Glioblastoma, International Publications /von 2019-06-17 / J Clin Oncol 37, 2019 (suppl; abstr e13526)

Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model-based characterization approach

2019-06-14/in Breast Cancer, Dendritic Cells, International Publications /von 2019-06-14 / Br J Clin Pharmacol 2019 Aug;85(8):1670-1683

Phase I/II Pilot Study of Wilms‘ Tumor 1 Peptide-Pulsed Dendritic Cell Vaccination Combined With Conventional Chemotherapy in Patients With Head and Neck Cancer

2019-06-06/in Dendritic Cells, International Publications /von 2019-06-06 / Ther Apher Dial 2019 Jun;23(3):279-288

A phase II open labeled, randomized study of poly-ICLC matured dendritic cells for NY-ESO-1 and Mean-A peptide vaccination compared to Montanide, in melanoma patients in complete clinical remission.

2019-06-03/in Dendritic Cells, International Publications, Malignant Melanoma /von 2019-06-03 / J Clin Oncol 37, 2019 (suppl; abstr 9538)